Clovis Highlights Pipeline Turnaround Going Into 2014
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The small oncology company has recovered from previous setbacks and is now anticipating a strong year to come as it moves two drugs into later-stage development and pivotal trials.